Ma and Zhang [4] found that diosmetin inhibits the proliferation of liver cancer cells by targeting checkpoint kinase 2 (Chk2) and promotes cancer cell apoptosis and cell cycle arrest. Here, CHEK2 is linked to liver cancer.